Romosozumab: A first-in-class sclerostin inhibitor for...

  • Main
  • 2020 / 09
  • Romosozumab: A first-in-class sclerostin inhibitor for...

Romosozumab: A first-in-class sclerostin inhibitor for osteoporosis

Prather, Caitlin, Adams, Erin, Zentgraf, Whitney
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
American Journal of Health-System Pharmacy
DOI:
10.1093/ajhp/zxaa285
Date:
September, 2020
File:
PDF, 188 KB
2020
Conversion to is in progress
Conversion to is failed